AVCTF
Price
$0.64
Change
-$0.03 (-4.48%)
Updated
Aug 1 closing price
Capitalization
248.5M
EPRX
Price
$5.33
Change
+$0.06 (+1.14%)
Updated
Aug 11 closing price
Capitalization
191M
Earnings call today
Interact to see
Advertisement

AVCTF vs EPRX

Header iconAVCTF vs EPRX Comparison
Open Charts AVCTF vs EPRXBanner chart's image
Avacta Group
Price$0.64
Change-$0.03 (-4.48%)
Volume$1K
Capitalization248.5M
Eupraxia Pharmaceuticals
Price$5.33
Change+$0.06 (+1.14%)
Volume$15.87K
Capitalization191M
AVCTF vs EPRX Comparison Chart in %
Loading...
AVCTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVCTF vs. EPRX commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVCTF is a Hold and EPRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 12, 2025
Stock price -- (AVCTF: $0.64 vs. EPRX: $5.32)
Brand notoriety: AVCTF and EPRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVCTF: 51% vs. EPRX: 136%
Market capitalization -- AVCTF: $248.5M vs. EPRX: $191M
AVCTF [@Biotechnology] is valued at $248.5M. EPRX’s [@Biotechnology] market capitalization is $191M. The market cap for tickers in the [@Biotechnology] industry ranges from $96.01B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVCTF’s FA Score shows that 0 FA rating(s) are green whileEPRX’s FA Score has 0 green FA rating(s).

  • AVCTF’s FA Score: 0 green, 5 red.
  • EPRX’s FA Score: 0 green, 5 red.
According to our system of comparison, both AVCTF and EPRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVCTF’s TA Score shows that 4 TA indicator(s) are bullish while EPRX’s TA Score has 2 bullish TA indicator(s).

  • AVCTF’s TA Score: 4 bullish, 5 bearish.
  • EPRX’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, AVCTF is a better buy in the short-term than EPRX.

Price Growth

AVCTF (@Biotechnology) experienced а 0.00% price change this week, while EPRX (@Biotechnology) price change was -1.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.03%. For the same industry, the average monthly price growth was +18.52%, and the average quarterly price growth was +17.78%.

Reported Earning Dates

EPRX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+8.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVCTF($248M) has a higher market cap than EPRX($191M). EPRX YTD gains are higher at: 67.981 vs. AVCTF (13.628).
AVCTFEPRXAVCTF / EPRX
Capitalization248M191M130%
EBITDAN/A-25.89M-
Gain YTD13.62867.98120%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A27.5M-
Total DebtN/A52.8K-
TECHNICAL ANALYSIS
Technical Analysis
AVCTFEPRX
RSI
ODDS (%)
Bearish Trend 1 day ago
43%
Bearish Trend 1 day ago
56%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
41%
Bullish Trend 1 day ago
67%
Momentum
ODDS (%)
Bearish Trend 1 day ago
53%
Bearish Trend 1 day ago
67%
MACD
ODDS (%)
Bearish Trend 1 day ago
50%
Bearish Trend 1 day ago
70%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
32%
Bearish Trend 1 day ago
65%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
33%
Bearish Trend 1 day ago
55%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 11 days ago
33%
Bearish Trend 4 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
67%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
27%
Bullish Trend 5 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
AVCTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYPFX9.030.01
+0.11%
Royce Small-Cap Fund Svc
BOYAX32.750.03
+0.09%
Boyar Value
GMUEX13.81-0.02
-0.14%
GMO US Equity III
ITCTX25.60-0.08
-0.31%
VY® T. Rowe Price Capital Apprec S2
JRSSX12.65-0.04
-0.32%
JH Adaptive Risk Mgd U.S. Eq S

AVCTF and

Correlation & Price change

A.I.dvisor tells us that AVCTF and NAUT have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AVCTF and NAUT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVCTF
1D Price
Change %
AVCTF100%
N/A
NAUT - AVCTF
29%
Poorly correlated
-1.60%
ACAD - AVCTF
24%
Poorly correlated
+0.89%
EPRX - AVCTF
24%
Poorly correlated
+1.24%
KZIA - AVCTF
23%
Poorly correlated
+0.62%
FBRX - AVCTF
23%
Poorly correlated
+3.29%
More

EPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, EPRX has been loosely correlated with NAGE. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if EPRX jumps, then NAGE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EPRX
1D Price
Change %
EPRX100%
+1.24%
NAGE - EPRX
33%
Loosely correlated
+0.92%
MDGL - EPRX
28%
Poorly correlated
+1.09%
IVEVF - EPRX
28%
Poorly correlated
N/A
ACAD - EPRX
28%
Poorly correlated
+0.89%
CCCC - EPRX
25%
Poorly correlated
-3.20%
More